Optimal Timing and Failure Prediction of High Flow Nasal Cannula Oxygen Therapy in Emergency Department: Prospective Observational Single Center Study

Launched by YONSEI UNIVERSITY · Sep 26, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how to best use high flow nasal cannula (HFNC) oxygen therapy for adults who are having trouble breathing in the emergency department at Severance Hospital. The goal is to understand when to start HFNC and how to predict if it will be successful or if a patient will need a more invasive treatment, like intubation (where a tube is placed in the airway). Researchers will look at patients' vital signs and other health indicators before and after starting HFNC to help determine the best approach for treatment.

To be eligible for this study, patients must be adults who are experiencing breathing difficulties and are treated with HFNC in the emergency department. However, individuals under 18 years old or those who are not fully conscious will not be included. Participants can expect to have their health monitored closely, including assessments of their comfort and breathing, both before and after starting HFNC. This research aims to improve the care provided to patients with severe respiratory issues, potentially leading to better outcomes in emergency situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with dyspnea and applied to HFNC in ED at Severance Hospital.
• Exclusion Criteria:
• • age\<18
• • GCS ≤ 12
• • Do not resuscitate patients, whom wishes not to included in the study